From: ELITE II and Val-HeFT are different trials: together what do they tell us?
Study | Patients | Comparators | Size | Status |
---|---|---|---|---|
OPTIMAAL | Post-MI | Losartan vs captopril | n = 5477 | Recruitment complete; end date 2002 |
VALIANT | Post-MI | Valsartan vs captopril vs combination | n = 14500 | Recruitment complete; end date 2003 |
CHARM | CHF | Candesartan vs placebo | n = 2548 | Recruitment complete; end date 2003 |
 | CHF (ACE intolerant) | Candesartan vs placebo | n = 2028 | Recruitment complete |
 | Diastolic dysfunction | Candesartan vs placebo | n = 3024 | Recruitment complete |